Stock of pharma major Biocon has risen 60 percent from its March 2020 lows. The company is scheduled to report its Q3FY21 earnings tomorrow (January 21).
CNBC-TV18 poll suggest a revenue growth of 10 percent and margins are expected to come at around 25 percent.
Watch video for more.
(Edited by : Bivekananda Biswas)